Jinkō Modeling & Simulation: An in Silico Trial Simulation Platform

During this talk, we will showcase how knowledge is leveraged directly within jinkō to help lower the cost and ethical constraints as well as achieve greater trial efficiency through the design and simulation of in silico trials. This will be illustrated with two practical use cases using nova's non small cell lung cancer (NSCLC) disease model of epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma (LUAD). First, by exploring a large range of doses and then by testing eligibility criteria refinement and its impact on treatment effectiveness. For more information visit: https://www.novadiscovery.com/jinko/ *Contents* 00:00 - Introduction 06:26 - Presentation: Jinkō Modeling & Simulation: An in Silico Trial Simulation Platform Moderator: James A. Glazier, PhD, Indiana University, Bloomington If you found this video useful, please check out our other videos on computational modeling, infection and immunology: https://youtube.com/playlist?list=PLiEtieOeWbMKh9VcQoinSwODcSZKMTGat Please consider joining our IMAG/MSM WG on Multiscale Modeling and Viral Pandemics: https://www.imagwiki.nibib.nih.gov/content/msm-viral-pandemics-meetings Please also consider joining the Global Alliance for Immune Prediction and Intervention: http://glimprint.org/